Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2014
CVR: 13526990
Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 67,241,986 and a net result of DKK 5,823,204 compared with DKK 6,409,804 the year before. That is an increase of 0.2% compared with the year before. Equity amounted to DKK 20,048,560. The solvency ratio was 33.4%. The company had 29 employees in the financial year.
- Gross Profit
- 67,241,986 kr.
- Profit/Loss
- 5,823,204 kr.
- Equity
- 20,048,560 kr.
- Total Assets
- 60,113,814 kr.
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 67.2 mio. | 5.8 mio. | 20 mio. | 29 |
| 2013 | - | 67.1 mio. | 6.4 mio. | 20.2 mio. | 29 |
Keep an eye on Boehringer Ingelheim Animal Health Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2013. Gross profit came to DKK 67,122,372, and the net result was DKK 6,409,804.
As of May 23, 2014, Kirstin Jagd has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 23, 2014, Ann Jensen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
About Boehringer Ingelheim Animal Health Denmark A/S
Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.
